Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Neovasc Inc (NVCN)

Neovasc Inc (NVCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Neovasc Inc Suite 5138 - 13562 Maycrest Way RICHMOND A1 V6V 2J7 CAN

www.neovasc.com P: 604-248-4138 F: 604-270-4384

Description:

Neovasc Inc. is a specialty medical device company. It develops, manufactures and markets products for the cardiovascular marketplace. The Company's products include the Tiara (TM) mitral valve prosthesis in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer (TM) for the treatment of refractory angina and a line of advanced biological tissue products that are used as key components in third-party medical products, including transcatheter heart valves. Neovasc Inc. is headquartered in Richmond, Canada.

Key Statistics

Overview:

Market Capitalization, $K 82,375
Enterprise Value, $K 56,585
Shares Outstanding, K 2,743
Annual Sales, $ 3,810 K
Annual Net Income, $ -41,200 K
Last Quarter Sales, $ 1,450 K
Last Quarter Net Income, $ -13,840 K
60-Month Beta 1.70
% of Institutional Shareholders 1.64%
Float, K 2,743
% Float 100.00%
Short Volume Ratio 0.73

Growth:

1-Year Return 198.06%
3-Year Return -53.08%
5-Year Return -97.60%
5-Year Revenue Growth -29.31%
5-Year Earnings Growth 99.85%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -5.04 on 03/31/23
Latest Earnings Date 05/11/23
Earnings Per Share ttm -14.34
EPS Growth vs. Prev Qtr -68.00%
EPS Growth vs. Prev Year -124.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 04/29/22

NVCN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -127.26%
Return-on-Assets % -80.31%
Profit Margin % -1,081.36%
Debt/Equity 0.80
Price/Sales 21.30
Price/Cash Flow N/A
Price/Book 5.20
Book Value/Share 5.78
Interest Coverage -26.09
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar